基于TGF-β的疗法用于治疗眼睛表面疾病
Fernando T Ogata1, Sudhir Verma1,2, Vivien J Coulson-Thomas1
1College of Optometry, University of Houston, 4901 Calhoun Road, Houston, TX 77204, USA.
Cells
|July 12, 2024
概括
转化生长因子-β (TGF-β) 对于角膜伤口愈合至关重要,促进修复,但可能会导致过度水平的痕. 了解其异型 (TGF-β1-3) 是治疗开发的关键.
科学领域:
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 角膜损伤需要有效的愈合机制来进行结构和功能恢复.
- 转化生长因子-β (TGF-β) 是角膜伤口修复中的关键信号分子.
- TGF-β的失调与角膜病理,如痕和彼得异常有关.
研究的目的:
- 总结TGF-β异型在角膜伤口愈合中的复杂作用.
- 剖析TGF-β在角膜再生中的分子和细胞机制.
- 探索TGF-β在角膜病原和潜在的治疗策略中的参与.
主要方法:
- 关于角膜伤口愈合中的TGF-β信号传递现有文献的综述.
- 对TGF-β异形特异性功能 (TGF-β1,TGF-β2,TGF-β3) 的分析.
- 检查TGF-β在迁移,增殖和分化等细胞过程中的作用.
主要成果:
- TGF-β信号传递对于启动角膜修复过程至关重要,包括细胞迁移和肌纤维细胞分化.
- 虽然TGF-β水平升高对于关闭至关重要,但可以导致有害的纤维化和视力受损的痕.
- TGF-β1,TGF-β2和TGF-β3的不同作用有助于角膜愈合的复杂性.
结论:
- 准TGF-β通路为角膜伤口愈合和疾病的治疗干预提供了潜力.
- 对TGF-β机制的全面理解是必要的,以便开发用于角膜病理的有效治疗方法.
- 对TGF-β异形特异性作用的进一步研究可以完善视力恢复的治疗方法.
相关概念视频
01:27Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427
01:28Angle Closure Glaucoma: Treatment
470
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
470
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
128
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
128
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
114
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
114
01:16TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
01:25Glaucoma: Overview
538
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
538